Paclitaxel

related topics
{disease, patient, cell}
{acid, form, water}
{company, market, business}
{specie, animal, plant}
{work, book, publish}
{law, state, case}
{line, north, south}
{build, building, house}
{school, student, university}
{mi², represent, 1st}
{town, population, incorporate}

Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a U.S. National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani isolated it from the bark of the Pacific yew tree, Taxus brevifolia and named it taxol. When it was developed commercially by Bristol-Myers Squibb (BMS) the generic name was changed to paclitaxel and the BMS compound is sold under the trademark TAXOL. In this formulation, paclitaxel is dissolved in Cremophor EL and ethanol, as a delivery agent. A newer formulation, in which paclitaxel is bound to albumin, is sold under the trademark Abraxane.

Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is also used for the prevention of restenosis.

Paclitaxel stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division. Together with docetaxel, it forms the drug category of the taxanes. It was the subject of a notable total synthesis by Robert A. Holton.

While offering substantial improvement in patient care, paclitaxel has been a relatively controversial drug. There was originally concern because of the environmental impact of its original sourcing, no longer used, from the Pacific yew. In addition, the assignment of rights, and even the name itself, to Bristol-Myers Squibb were the subject of public debate and Congressional hearings.

Contents

Full article ▸

related documents
Rotavirus
Apoptosis
Respiratory system
Epinephrine
Creutzfeldt-Jakob disease
Glaucoma
Scar
Osteoporosis
HIV vaccine
Lassa fever
Cirrhosis
Lymph node
Dermatology
Typhoid fever
Botulism
Hernia
Ménière's disease
Intensive insulinotherapy
Metastasis
Vagus nerve
Sickle-cell disease
Chronic pain
Tetanus
Haemophilia
Urinary tract infection
Rett syndrome
Stimulant
Bloodletting
Temporomandibular joint disorder
Dieting